IRS2 is upregulated in the colon cancer tissues than its surrounding tissues, and the knockdown of IRS2 inhibits the proliferation and clonogenic ability of RKO cells, and increases apoptosis, suggesting that IRS2 may act as an oncogene in colon cancer (Zhong et al., 2015). Here, IRS2 is linked to malignant colon neoplasm.